Results 1 to 10 of about 520,129 (244)

Severe probable immune checkpoint inhibitor-related pneumonitis after thoracic radiotherapy complicated by acute pulmonary embolism in lung squamous cell carcinoma: a case report [PDF]

Frontiers in Medicine
Immune checkpoint inhibitor-related pneumonitis (CIP) is a potentially life-threatening adverse event in lung cancer. We report a case of severe probable CIP complicated by acute pulmonary embolism (PE) in a 76-year-old man with stage IIIA lung squamous ...
Fangping Luo, Wanli Zhu, Yali Yu, Hongling Hu, Yingshan Cui, Haiqing Pan   +5 more
doaj   +2 more sources

Hyperthermia correlates with low incidence of radiation pneumonitis after thoracic radiotherapy: a retrospective study [PDF]

BMC Cancer
Objective This study aims to investigate the impact of radiotherapy combined with hyperthermia (RHT) on the incidence of radiation pneumonitis (RP) in patients with thoracic malignancies. Method This study enrolled 233 patients with thoracic malignancies
Wentao Gao, Jiafeng Liang, Lingling Wang, Yanyan Zhao, Shenglin Ma, Lucheng Zhu   +5 more
doaj   +2 more sources

Establishment and validation of nomograms to predict survival probability of advanced malignant pleural mesothelioma based on the SEER database and a Chinese medical institution

Frontiers in Endocrinology, 2023
ObjectiveThe purpose of this study was to build nomograms for predicting the survival of individual advanced pleural mesothelioma (MPM) patients using the Surveillance, Epidemiology, and End Results (SEER) database.MethodsThe 1251 patients enrolled from ...
Xuemei Zhang, Lele Chang, Yingying Zhu, Yuxin Mao, Tao Zhang, Qian Zhang, Chunbo Wang   +6 more
doaj   +1 more source

Thyroid Dysfunction as a Predictive Indicator in Camrelizumab of Advanced Esophageal Squamous Cell Carcinoma

Journal of Immunology Research, 2022
Thyroid dysfunction (TD) induced by programmed death-1 (PD-1) or programmed cell death-ligand 1 (PD-L1) immune checkpoint inhibitors (ICIs) has been widely reported.
Ying Chen, Lei Zhuang, Danhong Zhang, Xianghui Du, Liming Sheng   +4 more
doaj   +1 more source

Survival benefit of thoracic radiotherapy plus EGFR-TKIs in patients with non-oligometastatic advanced non-small-cell lung cancer: a single-center retrospective study

Therapeutic Advances in Medical Oncology, 2023
Objectives: The study aims to evaluate the efficacy and safety of thoracic radiotherapy in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-treated patients with stage IV non-small-cell lung cancer (NSCLC).
Fangyuan Zhou, You Qin, Xixi Liu, Jing Huang, Bian Wu, Zhanjie Zhang, Zhongyuan Yin, Jinsong Yang, Sheng Zhang, Ke Jiang, Kunyu Yang   +10 more
doaj   +1 more source

E3 Ubiquitin Ligase CHIP Inhibits the Interaction between Hsp90β and MAST1 to Repress Radiation Resistance in Non-Small-Cell Lung Cancer Stem Cells

Stem Cells International, 2022
The radiation resistance of cancer stem cells poses a critical obstacle for management of non-small-cell lung cancer (NSCLC). It is interesting to note that E3 ubiquitin ligase CHIP is involved in radiation resistance and stemness phenotypes in NSCLC ...
Bo Tan, Jingwei Zhang, Wen Wang, Haibo Ma, Yuanyuan Yang   +4 more
doaj   +1 more source

Pseudoprogression of thoracic tumor after radiotherapy in the era of immunotherapy: a case series

Frontiers in Oncology, 2023
Pseudoprogression is rarely mentioned after radiotherapy except for central nervous system tumors. With the widespread of immunotherapy, the incidence of pseudoprogression of thoracic tumor after radiotherapy is increasing.
Yongbo Xiang, Wei Tang, Jianyang Wang, Zhijie Wang, Nan Bi   +4 more
doaj   +1 more source

Impact of thoracic tumor radiotherapy on survival in non‐small‐cell lung cancer with malignant pleural effusion treated with targeted therapy: Propensity score matching study

Cancer Medicine, 2023
Background EGFR‐mutant (EGFR‐M) and ALK‐positive (ALK‐P)are common in malignant pleural effusion (MPE) with metastatic non‐small‐cell lung cancer (NSCLC) (MPE‐NSCLC). The impact of thoracic tumor radiotherapy on survival in such patients remains unclear.
Qingsong Li, Cheng Hu, Shengfa Su, Zhu Ma, Yichao Geng, Yinxiang Hu, Haijie Jin, Huiqin Li, Bing Lu   +8 more
doaj   +1 more source

Overlap time is an independent risk factor of radiation pneumonitis for patients treated with simultaneous EGFR-TKI and thoracic radiotherapy

Radiation Oncology, 2021
Background The exact rate and relevant risk factors of radiation pneumonitis (RP) for non-small-cell cancer (NSCLC) patients treated with the combination of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) and thoracic radiotherapy
Wenxiao Jia, Qianqian Gao, Min Wang, Ji Li, Wang Jing, Jinming Yu, Hui Zhu   +6 more
doaj   +1 more source

Assessment of short-term effects of thoracic radiotherapy on the cardiovascular parasympathetic and sympathetic nervous systems

Frontiers in Neuroscience, 2023
BackgroundPrior research suggests that cardiovascular autonomic dysfunction might be an early marker of cardiotoxicity induced by antitumor treatment and act as an early predictor of cardiovascular disease-related morbidity and mortality.
Shuang Wu, Shuang Wu, Weizheng Guan, Weizheng Guan, Huan Zhao, Huan Zhao, Guangqiao Li, Guangqiao Li, Yufu Zhou, Bo Shi, Bo Shi, Xiaochun Zhang, Xiaochun Zhang   +12 more
doaj   +1 more source